Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/18/2025

Comprehensive Secondary Prevention of Coronary Artery Disease

Antiplatelet Therapy

  • The American College of Chest Physicians recommends long-term single antiplatelet therapy with aspirin 75-100 mg daily or clopidogrel 75 mg daily for patients with coronary artery disease 1
  • Single antiplatelet therapy is preferred over dual antiplatelet therapy for long-term management of patients with coronary artery disease 1
  • For patients without PCI, dual antiplatelet therapy with ticagrelor 90 mg twice daily plus low-dose aspirin, or clopidogrel 75 mg daily plus low-dose aspirin (ticagrelor preferred) is recommended 1
  • For patients with PCI and stent placement, dual antiplatelet therapy for 12 months with one of the following plus aspirin is recommended: ticagrelor 90 mg twice daily (preferred), clopidogrel 75 mg daily, or prasugrel 10 mg daily (avoid in patients >75 years, <60 kg, or with prior stroke/TIA) 1, 2
  • Prasugrel should be avoided in patients >75 years, <60 kg, or with history of stroke/TIA due to increased bleeding risk 1

Stent Management

  • For bare-metal stents, a minimum of 1 month of dual antiplatelet therapy is recommended 1
  • For drug-eluting stents, a minimum of 3-6 months of dual antiplatelet therapy is recommended 1
  • For all stents, considering continuing dual therapy for 12 months is recommended 1, 3

Lipid Management

  • The American College of Cardiology recommends LDL-C levels <100 mg/dL for patients with coronary artery disease 4
  • Further reduction of LDL-C to <70 mg/dL is reasonable for patients with coronary artery disease 4
  • For patients with triglycerides ≥200 mg/dL, non-HDL-C should be <130 mg/dL 4
  • Dietary therapy should aim to reduce saturated fats to <7% of calories, reduce trans fats, and limit cholesterol to <200 mg/day 4
  • Adding plant stanols/sterols (2g/day) and viscous fiber (10g/day) to further lower LDL-C is recommended 4
  • Statin therapy should be initiated for all patients with coronary artery disease 4
  • For patients with triglycerides 200-499 mg/dL, considering adding niacin or fibrate after LDL-C lowering therapy is recommended 4

Blood Pressure Management

  • The American College of Cardiology recommends blood pressure levels <140/90 mmHg for most patients with coronary artery disease 4
  • For patients with diabetes or chronic kidney disease, blood pressure levels <130/80 mmHg are recommended 4

Lifestyle Modifications

  • Lifestyle modifications including weight control, increased physical activity, alcohol moderation, sodium reduction, and increased consumption of fresh fruits, vegetables, and low-fat dairy products are recommended 4
  • 30-60 minutes of moderate-intensity aerobic activity on most, preferably all, days of the week is recommended 4, 3
  • Supplementing with increased daily lifestyle activities (walking breaks at work, gardening, household work) is recommended 4
  • Resistance training 2 days per week is reasonable 4, 3
  • Medically supervised programs for high-risk patients are recommended 4

Weight Management

  • The American College of Cardiology recommends a BMI of 18.5-24.9 kg/m² for patients with coronary artery disease 4, 3
  • Waist circumference should be <35 inches (89 cm) for women and <40 inches (102 cm) for men 4, 3
  • An initial weight loss goal of 5-10% from baseline is recommended 3
  • Achieving weight loss through balanced physical activity, caloric intake, and behavioral programs is recommended 4, 3

Diabetes Management

  • The American College of Cardiology recommends coordinating care with primary care physician or endocrinologist for patients with diabetes and coronary artery disease 3
  • Lifestyle modifications including physical activity, weight management, blood pressure control, and lipid management are recommended 3
  • Metformin is an effective first-line pharmacotherapy for patients with diabetes and coronary artery disease if not contraindicated 3
  • Target HbA1c of 7% may be considered, with individualization based on hypoglycemia risk 3
  • Avoiding overly aggressive glucose control in elderly patients or those with comorbidities is recommended, and individualizing HbA1c targets is recommended 3

Tobacco Cessation

  • The American College of Cardiology recommends asking about tobacco use at every visit, advising every tobacco user to quit, and assisting with counseling, quitting plan, and pharmacotherapy (nicotine replacement, bupropion) 4
  • Urging avoidance of environmental tobacco smoke is recommended 4

Vaccination

  • The American College of Cardiology recommends annual influenza vaccination for all patients with cardiovascular disease 4

Dual Antiplatelet Therapy

  • The American College of Chest Physicians recommends not continuing dual antiplatelet therapy indefinitely in stable CAD patients due to bleeding risk, and transitioning to single antiplatelet therapy after appropriate duration 1
  • When using warfarin plus antiplatelet therapy, increased bleeding risk requires close monitoring 4